Philips has entered into an agreement to acquire SpectraWave, a company specializing in AI-powered coronary intravascular imaging and physiological assessment technologies.
The acquisition includes SpectraWave’s HyperVue imaging system, which combines optical coherence tomography and near-infrared spectroscopy for enhanced vascular imaging, and X1-FFR, an angiography-based, AI-enabled fractional flow reserve tool that provides coronary physiology data from a single angiogram, according to a Dec. 15 news release.
Philips said the deal will expand its current intravascular portfolio, which includes its Eagle Eye Platinum digital intravascular ultrasound catheter and OmniWire iFR technology, and plans to integrate the technologies with its Azurion image-guided therapy platform.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.